US Stock Reports, Quotes and News
Gurmeet Chadha says one of the main issues with most EPC construction names is the working capital cycle and margins because the projects are long gestation, you do not know what commodity prices would behave and people have some memories of 2003 to 2008 when there was euphoria and followed by a 10-year hiatus.
Learn about the importance of alpha in investing and how it relates to active management. Chirag Muni of Anand Rathi Wealth explains how alpha measures excess returns against benchmarks, emphasizing the value it adds to investment decisions. Muni says alpha on a standalone basis may not be enough as one also needs to factor in risk, this is where beta comes into the picture.
Sanjiv Bhasin of IIFL Securities advises caution in investing in defence and railway stocks due to unfavorable prices. He mentions selectively booking profits in PSUs like Vedanta, Nalco, and SAIL, which have performed well in the metal space. Bhasin says he would put my money on Coforge and thinks this stock can revisit those levels of 6,000 once Cigniti acquisition goes through smoothly.
Analysts said Go Digit\’s position as the fastest-growing private non-life insurer by GWP in India positions it for continued success in the insurance market. The company\’s advanced technology platform and focus on innovation bode well for its future.
Cube Highways Trust declared an annual distribution per unit (DPU) of Rs 10.09 for FY24, with plans to acquire seven road assets, including six based on NHAI\’s Hybrid Annuity Model for revenue stability.
Among the public shareholders, foreign investors own about 19% stake in the company and mutual funds are holding 4.74%, according to the latest shareholding data available with the exchanges.
The brokerage has set a target price of Rs 1,075 for the stock. Bharti Airtel continues to be its chosen pick. ICICI Securities has assigned a 15% premium to Bharti India’s valuations. It stands by its hypothesis of ‘small, but beautiful’ for BHL.
ITC board declares a final dividend of Rs 7.5 per share alongside Q4 profit of Rs 5,120 crore, missing estimates. Total dividend for FY24 set at Rs 13.75 per share. Revenue up 2% YoY. Stock shows strong technical performance.
International funds, including top performers like Mirae Asset NYSE FANG+ETF FoF, showed strong growth. However, concerns arise with Sebi\’s restrictions on overseas ETF investments and varying earnings growth in indices like Hang Seng and CSI 300.
Sun Pharma Q4 Results: The company\’s revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed timeline. India formulations sales were Rs 3,707 crore for the fourth quarter, showing growth of 10% over Q4 last year and accounted for 31.4% of total consolidated sales for the quarter.
Weeks before vote counting set for June 4, stock markets are closely tracking shadow-betting platforms that are flourishing nationwide, with wagers now suggesting the ruling Bharatiya Janata Party (BJP) will win a slimmer majority than expected.
The overall bias remains on the positive side, and the Nifty seems to have stabilised near the 22,500 zones in the last 2-3 sessions despite volatility.